Association between alkaline phosphatase/albumin ratio and the prognosis in patients with chronic kidney disease stages 1–4: results from a C-STRIDE prospective cohort study

Association between alkaline phosphatase/albumin ratio and the prognosis in patients with chronic kidney disease stages 1–4: results from a C-STRIDE prospective cohort study

BackgroundThe alkaline phosphatase-to-albumin ratio (APAR) has been demonstrated to be a promising non-invasive biomarker for predicting prognosis in certain diseases. However, the relationship between APAR and prognosis in non-dialysis chronic kidney disease (CKD) patients remains unclear. This stu...

Full description

Bibliographic Details
Main Authors: Xue Xue, Jia-Xuan Li, Jin-Wei Wang, La-Mei Lin, Hong Cheng, Dan-Fang Deng, Wen-Cheng Xu, Yu Zhao, Xin-Rong Zou, Jun Yuan, Lu-Xia Zhang, Ming-Hui Zhao, Xiao-Qin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Medicine
Subjects:
alkaline phosphatase-to-albumin ratio
chronic kidney disease
end-stage kidney disease
major adverse cardiovascular and cerebrovascular events
all-cause death
cohort study
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1215318/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1215318/full

Similar Items